Resmed (RMD) Free Cash Flow (2009 - 2026)

Resmed (RMD) has 18 years of Free Cash Flow data on file, last reported at $520.5 million in Q1 2026.

• For the quarter ending Q1 2026, Free Cash Flow fell 6.7% year-over-year to $520.5 million; the trailing twelve-month figure through Mar 2026 stood at $1.8 billion (up 11.82% YoY), and the FY2025 full-year result was $1.7 billion, up 27.65% from the prior year.
• Free Cash Flow for Q1 2026 stood at $520.5 million, up from $311.2 million in the prior quarter.
• Across five years, Free Cash Flow topped out at $557.9 million in Q1 2025 and bottomed at $15.6 million in Q3 2022.
• The 5-year median for Free Cash Flow is $288.0 million (2024), against an average of $288.4 million.
• The widest annual swing landed in 2022, when Free Cash Flow slumped 74.4%; it then jumped 1541.98% in 2023.
• A 5-year view of Free Cash Flow shows it stood at $101.3 million in 2022, then jumped by 146.31% to $249.5 million in 2023, then rose by 15.43% to $288.0 million in 2024, then increased by 8.07% to $311.2 million in 2025, then jumped by 67.25% to $520.5 million in 2026.
• The last three Free Cash Flow figures came in at $520.5 million (Q1 2026), $311.2 million (Q4 2025), and $414.4 million (Q3 2025), per Business Quant data.

Peer Comparison